10x Genomics (TXG) Current Leases (2020 - 2026)

10x Genomics has disclosed Current Leases across 7 years of filings, most recently posting $12.0 million for Q2 2026.

• In Q2 2026, Current Leases rose 24.26% year-over-year to $12.0 million; the TTM figure through Jun 2026 stood at $12.0 million (up 24.26% YoY), while the FY2025 annual figure was $11.0 million, up 18.3% from the prior year.
• Current Leases came in at $12.0 million for Q2 2026 at 10x Genomics, up from $11.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $12.0 million in Q2 2026 to a low of $7.6 million in Q1 2022.
• Average Current Leases over 5 years is $9.9 million, with a median of $9.6 million recorded in 2025.
• Year-over-year, Current Leases soared 88.02% in 2022 and declined 19.4% in 2024.
• Over 5 years, Current Leases stood at $9.0 million in 2022, then gained by 27.49% to $11.5 million in 2023, then fell by 19.4% to $9.3 million in 2024, then gained by 18.3% to $11.0 million in 2025, then increased by 9.38% to $12.0 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $12.0 million in Q2 2026, $11.3 million in Q1 2026, and $11.0 million in Q4 2025.